Showing results (171-180 of 264) with videos related to

Sort By:
Pageof 27
Acta Oto-Laryngologica|November 8, 2012
p16 immunohistochemistry alone is a better prognosticator in tonsil cancer than human papillomavirus in situ hybridization with or without p16 immunohistochemistryKwonoh Park, Kyung Ja Cho, Miji Lee, et al.
Oncotarget|October 21, 2016
Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab eraSeyoung Seo, Jung Yong Hong, Shinkyo Yoon, et al.
Cancer Chemotherapy and Pharmacology|October 5, 2011
Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up dataDong Hoe Koo, Seung-Il Park, Yong-Hee Kim, et al.
The Korean Journal of Internal Medicine|September 11, 2015
The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in KoreaCheolsu Kim, Ho Sup Lee, Chang-Ki Min, et al.
Annals of Hematology|April 6, 2018
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysisJung Yong Hong, Dok Hyun Yoon, Cheolwon Suh, et al.
Clinical Hematology International|August 11, 2025
Consensus Guidelines and Recommendations for the anti-CD38-based Therapy in Clinical Practice for Relapsed/Refractory Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working GroupWenming Chen, Zhen Cai, Chor Sang Chim, et al.
Blood Research|January 16, 2016
Intraocular lymphoma in Korea: the Consortium for Improving Survival of Lymphoma (CISL) studySeul Lee, Moon Jin Kim, Jin Seok Kim, et al.
Annals of Hematology|June 28, 2018
Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma studySung Yong Oh, Won Seog Kim, Hye-Jin Kang, et al.
Biochemical and Biophysical Research Communications|June 25, 2023
The comprehensive expression of BCL2 family genes determines the prognosis of diffuse large B-cell lymphomaJin Roh, Hyo-Kyung Pak, Seongfeel Jeong, et al.
Cancer Research and Treatment|December 17, 2020
Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin LevelsHyung-Don Kim, Hyungwoo Cho, Shin Kim, et al.
Pageof 27